Endoscopic Management of Gastrointestinal Motility Disorders – Part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Total Page:16
File Type:pdf, Size:1020Kb
Published online: 2020-05-27 Guideline Endoscopic management of gastrointestinal motility disorders – part 2: European Society of Gastrointestinal Endoscopy (ESGE) Guideline Authors BasL.A.M.Weusten1,2, Maximilien Barret3,AlbertJ.Bredenoord4, Pietro Familiari5, Jean-Michel Gonzalez6,JeaninE. van Hooft4, Vicente Lorenzo-Zúñiga7,HubertLouis8,JanMartinek9, Suzanne van Meer1,2, Helmut Neumann10,Daniel Pohl11,FredericPrat3, Daniel von Renteln12, Edoardo Savarino13,RamiSweis14, Jan Tack15, Radu Tutuian16, Sauid Ishaq17 Institutions 15 Department of Gastroenterology, University Hospitals 1 Department of Gastroenterology and Hepatology, Leuven, Leuven, Belgium University Medical Center Utrecht, Utrecht University, 16 Department of Gastroenterology, University Clinic for The Netherlands Visceral Surgery and Medicine, Bern University 2 Department of Gastroenterology and Hepatology, St Hospital, Bern, Switzerland Antonius Hospital, Nieuwegein, The Netherlands 17 Department of Gastroenterology, Dudley Group NHS 3 Department of Gastroenterology and Digestive Foundation Trust and Birmingham City University, Oncology, Cochin Hospital, Assistance Publique- Birmingham, UK Hopitaux de Paris and University of Paris, France 4 Department of Gastroenterology, Amsterdam UMC, Bibliography Location AMC, Amsterdam, The Netherlands DOI https://doi.org/10.1055/a-1171-3174 5 Digestive Endoscopy Unit, Università Cattolica del Published online: 2020 | Endoscopy Sacro Cuore, Fondazione Policlinico Universitario A. © Georg Thieme Verlag KG Stuttgart · New York Gemelli, IRCCS, Rome, Italy ISSN 0013-726X 6 Department of Gastroenterology, Hôpital Nord, Marseille, France Corresponding author 7 Endoscopy Unit, University Hospital La Fe, Valencia, Bas L.A.M. Weusten, MD, PhD, Dept of Gastroenterology Spain and Hepatology, University Medical Center Utrecht, 8 Department of Gastroenterology, Internal mail no F02.618, P.O. Box 85500, 3508 GA Hepatopancreatology and Digestive Oncology, Erasme UTRECHT, The Netherlands Hospital, Université Libre de Bruxelles, Brussels, [email protected] Belgium 9 Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, Prague, Czech Appendix 1s– 3s Republic Online content viewable at: This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. 10 Department of Medicine I, University Medical Center https://doi.org/10.1055/a-1171-3174 Mainz, Mainz, Germany 11 Department of Health Sciences, Beaujon Hospital, Clichy, Assistance Publique-Hôpitaux de Paris and MAIN RECOMMENDATIONS University of Paris, Paris, France ESGE suggests flexible endoscopic treatment over open 12 Division of Gastroenterology, Montréal University surgical treatment as first-line therapy for patients with a Hospital (CHUM), Montréal, Canada symptomatic Zenker’s diverticulum of any size. 13 Department of Surgery, Oncology and Weak recommendation, low quality of evidence, level of Gastroenterology, DiSCOG, University of Padova, agreement 100%. Padova, Italy 14 Department of Gastroenterology, University College ESGE recommends that emerging treatments for Zenker’s London Hospital, London, UK diverticulum, such as Zenker’s peroral endoscopic myotomy (Z-POEM) and tunneling, be considered as experimental; Weusten Bas L.A.M. et al. Endoscopic management of GI motility disorders, part 2 … Endoscopy http://guide.medlive.cn/ Guideline these treatments should be offered in a research setting Strong recommendation, low quality evidence, level of only. agreement 100%. Strong recommendation, low quality of evidence, level of agreement 100%. ESGE recommends endoscopic cecostomy only after con- servative management with medical therapies or retro- ESGE recommends against the widespread clinical use of grade lavage has failed. transoral incisionless fundoplication (TIF) as an alternative Strong recommendation, low quality evidence, level of to proton pump inhibitor (PPI) therapy or antireflux surgery agreement 93.3%. in the treatment of gastroesophageal reflux disease (GERD), because of the lack of data on the long-term outcomes, the ESGE recommends fixing the cecum to the abdominal wall inferiority of TIF to fundoplication, and its modest efficacy at three points (using T-anchors, a double-needle suturing in only highly selected patients. TIF may have a role for device, or laparoscopic fixation) to prevent leaks and infec- patients with mild GERD who are not willing to take PPIs or tious adverse events, whatever percutaneous endoscopic undergo antireflux surgery. cecostomy method is used. Strong recommendation, moderate quality of evidence, Strong recommendation, very low quality evidence, level of level of agreement 92.8%. agreement 86.7%. ESGE recommends against the use of the Medigus ultraso- ESGE recommends considering endoscopic decompression nic surgical endostapler (MUSE) in clinical practice because of the colon in patients with Ogilvie’s syndrome that is not of insufficient data showing its effectiveness and safety in improving with conservative treatment. patients with GERD. MUSE should be used in clinical trials Strong recommendation, low quality evidence, level of only. agreement 93.8%. Strong recommendation, low quality evidence, level of agreement 100%. ESGE recommends prompt endoscopic decompression if the cecal diameter is > 12cm and if the Ogilvie’ssyndrome ESGE recommends against the use of antireflux mucosec- exists for a duration of longer than 4– 6days. tomy (ARMS) in routine clinical practice in the treatment of Strong recommendation, low quality evidence, level of GERD because of the lack of data and its potential complica- agreement 87.5%. tions. 2 Methodology SOURCE AND SCOPE The ESGE commissioned this Guideline (Guideline Committee This Guideline is an official statement of the European So- chair, J.v.H.) and appointed a Guideline leader (B.W.); he identi- ciety of Gastrointestinal Endoscopy (ESGE). It provides fied six clinical conditions of abnormal GI motility in which guidance on the endoscopic management of Zenker’sdi- therapeutic endoscopy is one of the treatment possibilities: verticulum, gastroesophageal reflux disease, intractable Zenker’s diverticulum, achalasia, GERD, gastroparesis, intract- constipation, and Ogilvie’s syndrome. The Grading of Re- able constipation, and Ogilvie’s syndrome. These six areas commendations Assessment, Development, and Evalua- were at a later stage agreed on by the Guideline committee tion (GRADE) system was adopted to define the strength members. of recommendations and the quality of evidence. In March 2018, an email was sent out to several key opinion This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. leaders in the field of therapeutic endoscopy to identify poten- tial Guideline committee members. Individual ESGE members were informed about this Guideline and were asked to apply if they were interested in participating with this Guideline. Three 1Introduction individual members (V.L.-Z., H.L., and F.P.) were selected based Therapeutic gastrointestinal (GI) endoscopy is rapidly evolving. on their expertise and scientific output. In addition, the Europe- Its role in the management of motility disorders of the diges- an Society of Neurogastroenterology and Motility (ESNM) was tive tract is increasing. The purpose of this Guideline is to pro- approached for collaboration andscientificinput.Asaresult, vide guidance on various aspects of the endoscopic manage- the ESNM appointed on request four Guideline committee ment of GI motility disorders. This is the second of two parts members regarded as experts in the field of GI motility and of the guideline, and is dedicated to Zenker’s diverticulum, gas- therapy (D.P., E.S., J.T., and R.T.). Finally, a Guideline commit- troesophageal reflux disease (GERD), intractable constipation, tee was formed comprising 18 members, and covering the six and Ogilvie’s syndrome. The first part, published as a separate areas of this guideline. Six task forces were created, based on manuscript, focused on achalasia and gastroparesis. the six clinical conditions. Each task force had one or two task Weusten Bas L.A.M. et al. Endoscopic management of GI motility disorders, part 2 … Endoscopy http://guide.medlive.cn/ 3, neither disagree nor agree; 4, agree; 5, strongly agree). A re- ABBREVIATIONS commendation was approved if >75% of the members agreed ARMS antireflux mucosectomy (reflected by a Likert score of 4– 5). In total three iterations of CT computed tomography the online voting process were needed to come to the final EGJ esophagogastric junction document. EMR endoscopic mucosal resection In January 2020, a draft prepared by B.W. was sent to all ESD endoscopic submucosal dissection group members. After the agreement of all group members ESGE European Society of Gastrointestinal Endos- had been obtained, the manuscript was reviewed by the ESGE copy Guideline Committee Chair (J.v.H.) and two external reviewers, ESNM European Society of Neurogastroenterology and was sent for further comments to the ESGE national socie- and Motility ties and individual members. After this, it was submitted to GERD gastroesophageal reflux disease Endoscopy for publication. GI gastrointestinal G-POEM gastric peroral endoscopic myotomy ’ GRADE Grading of Recommendations Assessment, 3Zenkers diverticulum Development, and Evaluation Zenker’s diverticulum is a pulsion diverticulum that develops in LAPEC laparoscopically assisted percutaneous an area of weakness of the posterior hypopharynx